Vir Biotechnology, Inc.
NASDAQ:VIRBiotechnology
Healthcare
$9.15 -2.63%
-$0.25 today
- Market cap
- $1.57B
- Beta
- 1.64
- P/E (TTM)
- -3.0
- EPS (TTM)
- -$3.00
52W Low $4.16High $11.66
Volume 2.15M
Average 1.76M
Balance Sheet
Inspect the capital base behind the business.
Assets
$1.00B
FY 2025 · Annual
-28.3% YoYLiabilities
$237.55M
FY 2025 · Annual
-4.4% YoYEquity
$765.28M
FY 2025 · Annual
-33.5% YoYBalance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 347.82M | 848.63M | 241.58M | 222.95M | 234.11M |
| Short-term Investments | 360.33M | 1.55B | 1.28B | 682.4M | 228.75M |
| Net Receivables | 773.08M | 0 | 0 | 0 | 3.6M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 8.59M | 59.2M | 65.82M | 137.11M | 47.62M |
| Total Current Assets | 1.56B | 2.52B | 1.59B | 1.04B | 514.08M |
| Property, Plant & Equipment (Net) | 130.05M | 188.17M | 167.2M | 122.86M | 117.72M |
| Goodwill | 16.94M | 16.94M | 16.94M | 16.94M | 16.94M |
| Intangible Assets | 33.29M | 32.76M | 22.57M | 8.1M | 7.85M |
| Long-term Investments | 201.39M | 23.93M | 105.28M | 190.02M | 314.58M |
| Tax Assets | 0 | 249.72M | 0 | 0 | 0 |
| Other Non-current Assets | 9.78M | (228.5M) | 18.86M | 18.42M | 31.66M |
| Total Non-current Assets | 391.45M | 283.01M | 330.83M | 356.33M | 488.74M |
| Total Assets | 1.95B | 2.8B | 1.92B | 1.4B | 1B |
| Account Payables | 6.52M | 6.42M | 6.33M | 5.08M | 9.8M |
| Short-term Debt | 0 | 0 | 0 | 0 | 8.8M |
| Tax Payables | 6.22M | 15.23M | 149K | 0 | 0 |
| Deferred Revenue | 98.21M | 15.52M | 64.85M | 12.65M | 0 |
| Other Current Liabilities | 0 | 7.65M | 9.35M | 16.06M | 74.21M |
| Total Current Liabilities | 341.24M | 511.03M | 175.41M | 119.66M | 92.82M |
| Long-term Debt | 0 | 0 | 0 | 0 | 89.05M |
| Deferred Tax Liabilities | 18.44M | 3.25M | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 3.82M | 53.21M | 1.53M | 0 | 0 |
| Other Non-current Liabilities | 25.36M | 32.8M | 40.22M | 38.63M | (33.38M) |
| Total Non-current Liabilities | 181.18M | 213.1M | 153.42M | 128.77M | 144.73M |
| Total Liabilities | 522.42M | 724.13M | 328.82M | 248.43M | 237.55M |
| Common Stock | 13K | 13K | 13K | 14K | 14K |
| Retained Earnings | (138.6M) | 377.24M | (237.82M) | (759.78M) | (1.2B) |
| Accumulated OCI | (1.1M) | (9.12M) | (815K) | (1.72M) | (2.06M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 1.43B | 2.08B | 1.59B | 1.15B | 765.28M |
| Total Debt | 137.49M | 127.97M | 124.54M | 97.89M | 186.91M |
| Net Debt | (210.33M) | (720.66M) | (117.04M) | (125.06M) | (47.2M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $276.1M |
| Short-term Investments | $196.3M |
| Other Current | $50.6M |
| Total Current Assets | $523.0M |
| PP&E (Net) | $113.9M |
| Goodwill | $16.9M |
| Intangible Assets | $7.8M |
| Long-term Investments | $333.0M |
| Other Non-current | $31.0M |
| Total Non-current Assets | $502.6M |
| Total Assets | $1.0B |
Analysis
Selected assets total $1.0B for Latest. The largest visible component is Long-term Investments at $333.0M, about 32.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 424B5 | 424B5 filing | Nov 12, 2026 | |
| S-3ASR | S-3ASR filing | Nov 12, 2026 | |
| SC 13G | SC 13G filing | Nov 10, 2026 | |
| 8-K | Current report | Nov 9, 2026 | |
| SC 13D/A | SC 13D/A filing | Nov 6, 2026 |
How much cash does VIR have?
Vir Biotechnology, Inc. (VIR) reported $234.11M in cash and equivalents in fiscal 2025.
How much debt does VIR carry?
Vir Biotechnology, Inc. (VIR) reported $186.91M of total debt, with net debt of -$47.20M.
Continue the stock analysis
Jump to another research area for this company.